Sio Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$29.7M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$27.3M |
| 3 |
Corcept Therapeutics
CORT
|
+$25.2M |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$47.4M |
| 2 |
Sanofi
SNY
|
+$34.1M |
| 3 |
Celcuity
CELC
|
+$30.9M |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.44% |
| 2 | Industrials | 7.07% |
| 3 | Consumer Staples | 0% |
No holdings matched the selected filter criteria.
Similar funds
Sio Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Sio Capital Management held 90 positions worth $697M, up 9.7% from $636M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Sio Capital Management deployed $92.3M of net new capital in Q1 2026, opening 22 new positions and adding to 24 existing holdings. Its largest new stake was Corcept Therapeutics: 674,759 shares worth $27.2M.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 84% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Sanofi, an estimated $34.1M trimmed.
- Sio Capital Management's largest Q1 2026 buy was Corcept Therapeutics: 674,759 shares worth $27.2M.
- Sio Capital Management added most to Cencora in Q1 2026, an estimated $29.7M increase.
- Sio Capital Management's biggest Q1 2026 reduction was Sanofi, cutting an estimated $34.1M.
- Sio Capital Management fully exited Cigna in Q1 2026, selling an estimated $47.4M.
- Sio Capital Management's ten largest holdings make up 45% of its $697M portfolio in Q1 2026.
- Sio Capital Management opened 22 new positions and closed 14 in Q1 2026.
- Sio Capital Management's portfolio value rose 9.7% quarter-over-quarter to $697M.
Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.